Please login to the form below

Not currently logged in
Email:
Password:

Former Roche CEO and chairman joins Arix Bioscience

Dr Franz Humer becomes a senior independent director

Arix Bioscience Dr Franz HumerHealthcare and life science company Arix Bioscience has appointed Dr Franz Humer as a senior independent director.

Most recently, Dr Humer served as chairman and chief executive at Roche, having joined the company as head of pharmaceuticals in 1995 before becoming chief operating officer in 1996.

He is currently chairman of Diageo, a consumer goods company, and a non-executive director of Chugai Pharmaceuticals, Citigroup and Kite Pharma.

Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz's stature.

“His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.

“Franz further strengthens a very experience board of executive and non-executive directors.”

10th November 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics